Product Code: ETC9563229 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Postmenopausal Vaginal Atrophy Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Postmenopausal Vaginal Atrophy Drugs Market - Industry Life Cycle |
3.4 Sweden Postmenopausal Vaginal Atrophy Drugs Market - Porter's Five Forces |
3.5 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
4 Sweden Postmenopausal Vaginal Atrophy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about postmenopausal vaginal atrophy (PVA) among women |
4.2.2 Growing acceptance of hormone replacement therapy for PVA treatment |
4.2.3 Rising demand for innovative non-hormonal treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the PVA market |
4.3.2 Limited availability of approved drugs for postmenopausal vaginal atrophy |
4.3.3 High costs associated with PVA drug development and marketing |
5 Sweden Postmenopausal Vaginal Atrophy Drugs Market Trends |
6 Sweden Postmenopausal Vaginal Atrophy Drugs Market, By Types |
6.1 Sweden Postmenopausal Vaginal Atrophy Drugs Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Estrogen Based Drugs, 2021- 2031F |
6.1.4 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Non Estrogen Based Drugs, 2021- 2031F |
6.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market, By Drug Form |
6.2.1 Overview and Analysis |
6.2.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Vaginal Gels, 2021- 2031F |
6.2.3 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.4 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2.5 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Rings, 2021- 2031F |
6.2.6 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Patches, 2021- 2031F |
7 Sweden Postmenopausal Vaginal Atrophy Drugs Market Import-Export Trade Statistics |
7.1 Sweden Postmenopausal Vaginal Atrophy Drugs Market Export to Major Countries |
7.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Imports from Major Countries |
8 Sweden Postmenopausal Vaginal Atrophy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for non-hormonal PVA drugs in Sweden |
8.2 Patient adherence rates to prescribed PVA treatments |
8.3 Percentage of women diagnosed with PVA seeking medical intervention |
9 Sweden Postmenopausal Vaginal Atrophy Drugs Market - Opportunity Assessment |
9.1 Sweden Postmenopausal Vaginal Atrophy Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
10 Sweden Postmenopausal Vaginal Atrophy Drugs Market - Competitive Landscape |
10.1 Sweden Postmenopausal Vaginal Atrophy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Postmenopausal Vaginal Atrophy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |